Michelle Rheault, MD
@rheaultm.bsky.social
Ped nephrologist, Division director, #NephJC, MN girl, COI: several. Alis volat propriis. Breast cancer survivor, Pronounced “row”, (she/her). Bluesky is not a dating app.
Pinned
As a former first generation medical student, loans were vital to allow me to follow my dream of being a doctor. This is a travesty.
Under new Trump administration rules, students won't be able to borrow as much for medical or nursing school or some other health professions. n.pr/49F5HOn
New limits on school loans could narrow physician and nurse pipeline, educators warn
Under new Trump administration rules, students won't be able to borrow as much for medical or nursing school or some other health professions.
n.pr
November 25, 2025 at 2:45 PM
As a former first generation medical student, loans were vital to allow me to follow my dream of being a doctor. This is a travesty.
Reposted by Michelle Rheault, MD
An announcement
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
Taking the reigns — NephJC
In April 2014, Swapnil and I launched NephJC—and within weeks we were overwhelmed by the sheer work of running a twice-monthly, Twitter-based journal club. Fortunately, we also had a deep bench of fri...
www.nephjc.com
November 25, 2025 at 12:03 PM
An announcement
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
www.nephjc.com/news/2025/11...
#NephJC
@kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
Reposted by Michelle Rheault, MD
Nephrology wasn’t a planned choice for me, but with time I genuinely fell in love with it.
November 24, 2025 at 1:41 AM
Nephrology wasn’t a planned choice for me, but with time I genuinely fell in love with it.
My first choice peds rotations (NICU, Heme/onc) were full and all that was left was nephrology. 🤷♀️ Guess I loved it.
November 23, 2025 at 9:23 PM
My first choice peds rotations (NICU, Heme/onc) were full and all that was left was nephrology. 🤷♀️ Guess I loved it.
Go see live music! 🇳🇿
m.youtube.com/watch?v=lRMo...
m.youtube.com/watch?v=lRMo...
November 23, 2025 at 1:32 AM
Go see live music! 🇳🇿
m.youtube.com/watch?v=lRMo...
m.youtube.com/watch?v=lRMo...
Reposted by Michelle Rheault, MD
Guess what NIH funded friends. No more paylines! This will be replaced by an entirely opaque system that appears to bool down to “whatever we want.”
They have destroyed the meritorious peer review system. Score will just be “considered”.
grants.nih.gov/news-events/...
They have destroyed the meritorious peer review system. Score will just be “considered”.
grants.nih.gov/news-events/...
Implementing a Unified NIH Funding Strategy to Guide Consistent and Clearer Award Decisions | Grants & Funding
grants.nih.gov
November 22, 2025 at 12:51 AM
Guess what NIH funded friends. No more paylines! This will be replaced by an entirely opaque system that appears to bool down to “whatever we want.”
They have destroyed the meritorious peer review system. Score will just be “considered”.
grants.nih.gov/news-events/...
They have destroyed the meritorious peer review system. Score will just be “considered”.
grants.nih.gov/news-events/...
Reposted by Michelle Rheault, MD
The US government spent over $27 billion from 2015 to 2022 on drugs with deferred or incomplete pediatric trials mandated by the Pediatric Research Equity Act, which affects compliance with required testing before drug approval. ja.ma/3LVGR2Q
November 21, 2025 at 1:00 PM
The US government spent over $27 billion from 2015 to 2022 on drugs with deferred or incomplete pediatric trials mandated by the Pediatric Research Equity Act, which affects compliance with required testing before drug approval. ja.ma/3LVGR2Q
Reposted by Michelle Rheault, MD
Every year, #NephJC celebrates successful, practice-changing trials. ✨ Which trials do you think are deserving for #TopNephrology 2025? #nephsky
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
Top Stories in Nephrology 2024 — NephJC
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every b...
www.nephjc.com
November 20, 2025 at 10:42 PM
Every year, #NephJC celebrates successful, practice-changing trials. ✨ Which trials do you think are deserving for #TopNephrology 2025? #nephsky
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
👇👇 Here's a throwback for 2024
www.nephjc.com/news/2024/1/...
Reposted by Michelle Rheault, MD
Check out the awesome visual abstract by @salinesolut.bsky.social
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
ORIGIN-3: The Visual Abstract — NephJC
Atacicept, BAFF/APRIL inhibition in IgAN
www.nephjc.com
November 18, 2025 at 12:32 PM
Check out the awesome visual abstract by @salinesolut.bsky.social
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
Attacking the origins of IgAN with atacicept ⚔️
www.nephjc.com/news/2025/11/17/origin-3-the-visual-abstract
From RAAS blockade to regenerative medicine: evolving treatment strategies in #Alport syndrome pubmed.ncbi.nlm.nih.gov/41243004/
November 17, 2025 at 3:54 PM
From RAAS blockade to regenerative medicine: evolving treatment strategies in #Alport syndrome pubmed.ncbi.nlm.nih.gov/41243004/
Just found out that a planned Thanksgiving guest follows Halal. Other than getting a Halal turkey, anything else I need to change? Trying to be respectful but don’t know much about this.
a turkey is sitting on a plate on a table surrounded by plates of food
ALT: a turkey is sitting on a plate on a table surrounded by plates of food
media.tenor.com
November 17, 2025 at 3:49 AM
Just found out that a planned Thanksgiving guest follows Halal. Other than getting a Halal turkey, anything else I need to change? Trying to be respectful but don’t know much about this.
Reposted by Michelle Rheault, MD
2025 AJKD Editors' Choice Award winning article: Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study
bit.ly/3WeEZ72
#VisualAbstract
bit.ly/3WeEZ72
#VisualAbstract
November 16, 2025 at 5:01 PM
2025 AJKD Editors' Choice Award winning article: Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study
bit.ly/3WeEZ72
#VisualAbstract
bit.ly/3WeEZ72
#VisualAbstract
Reposted by Michelle Rheault, MD
📣 Navigating the Challenges of #IgA Nephropathy and IgA #Vasculitis Nephritis in #Children
Check out 👀 @md_abdulqader83 & @LittleBeans22 on #kireportscommunity educational page
https://ow.ly/Tj0S50Xh8zW
#IgANephropathy #PediatricNephrology #NephrologyEducation
Check out 👀 @md_abdulqader83 & @LittleBeans22 on #kireportscommunity educational page
https://ow.ly/Tj0S50Xh8zW
#IgANephropathy #PediatricNephrology #NephrologyEducation
October 24, 2025 at 7:55 PM
📣 Navigating the Challenges of #IgA Nephropathy and IgA #Vasculitis Nephritis in #Children
Check out 👀 @md_abdulqader83 & @LittleBeans22 on #kireportscommunity educational page
https://ow.ly/Tj0S50Xh8zW
#IgANephropathy #PediatricNephrology #NephrologyEducation
Check out 👀 @md_abdulqader83 & @LittleBeans22 on #kireportscommunity educational page
https://ow.ly/Tj0S50Xh8zW
#IgANephropathy #PediatricNephrology #NephrologyEducation
Some days you just deserve ice cream. 🍦
November 15, 2025 at 11:34 PM
Some days you just deserve ice cream. 🍦
Clinical Variability of ADPKD in Monozygotic Twins www.kireports.org/article/S246...
November 15, 2025 at 2:50 PM
Clinical Variability of ADPKD in Monozygotic Twins www.kireports.org/article/S246...
Reposted by Michelle Rheault, MD
truth is stranger than fiction, FDA and VP edition
now, RCTs are not the be all and end all - biological plausibility is sometimes good enough?
www.nejm.org/doi/full/10....
@nejm.org perspective from Makary and Prasad
now, RCTs are not the be all and end all - biological plausibility is sometimes good enough?
www.nejm.org/doi/full/10....
@nejm.org perspective from Makary and Prasad
FDA’s New Plausible Mechanism Pathway | NEJM
Personalized therapies hold tremendous promise but challenge traditional models of drug and biologic development. The FDA outlines a path to market entry for products where a randomized trial is no...
www.nejm.org
November 14, 2025 at 6:46 PM
truth is stranger than fiction, FDA and VP edition
now, RCTs are not the be all and end all - biological plausibility is sometimes good enough?
www.nejm.org/doi/full/10....
@nejm.org perspective from Makary and Prasad
now, RCTs are not the be all and end all - biological plausibility is sometimes good enough?
www.nejm.org/doi/full/10....
@nejm.org perspective from Makary and Prasad
Reposted by Michelle Rheault, MD
Sharing our preprint - Multidisciplinary approach w/ biobank/EHR data, functional testing, genetic testing lab collaborations to reclassify 20 VUS in Alport syndrome, pkd. @amoralescgc.bsky.social @jeffminerphd.bsky.social www.medrxiv.org/content/10.1...
Leveraging genomic biobanks to enhance genetic testing outcomes for kidney disease
Chronic kidney disease (CKD) affects 9.1% globally and is associated with significant morbidity and mortality. While up to 10% of CKD cases yield a genetic diagnosis with hundreds of implicated genes ...
www.medrxiv.org
November 14, 2025 at 2:54 AM
Sharing our preprint - Multidisciplinary approach w/ biobank/EHR data, functional testing, genetic testing lab collaborations to reclassify 20 VUS in Alport syndrome, pkd. @amoralescgc.bsky.social @jeffminerphd.bsky.social www.medrxiv.org/content/10.1...
Reposted by Michelle Rheault, MD
Hey #NephSky: Would you like to contribute your answer to our next "5 Nephrologists, 1 Question" column? The question: What recent research has most changed your approach to managing glomerulonephritis? If you want to answer this or a future question, drop a comment.
November 11, 2025 at 9:55 PM
Hey #NephSky: Would you like to contribute your answer to our next "5 Nephrologists, 1 Question" column? The question: What recent research has most changed your approach to managing glomerulonephritis? If you want to answer this or a future question, drop a comment.
Triple Renin-Angiotensin System/Sodium-Glucose Transporter 2/Glycogen Synthase Kinase-3 Beta Inhibition for the Progression of CKD in Col4a3 -/- Mice with #Alport Nephropathy pubmed.ncbi.nlm.nih.gov/41201847/
Triple Renin-Angiotensin System/Sodium-Glucose Transporter 2/Glycogen Synthase Kinase-3 Beta Inhibition for the Progression of CKD in Col4a3 -/- Mice with Alport Nephropathy - PubMed
Triple Renin-Angiotensin System/Sodium-Glucose Transporter 2/Glycogen Synthase Kinase-3 Beta Inhibition for the Progression of CKD in Col4a3 -/- Mice with Alport Nephropathy
pubmed.ncbi.nlm.nih.gov
November 12, 2025 at 1:10 AM
Triple Renin-Angiotensin System/Sodium-Glucose Transporter 2/Glycogen Synthase Kinase-3 Beta Inhibition for the Progression of CKD in Col4a3 -/- Mice with #Alport Nephropathy pubmed.ncbi.nlm.nih.gov/41201847/
Reposted by Michelle Rheault, MD
A follow-up report showed that the overall benefit of machine perfusion over cold storage in kidney graft survival remained present 10 years after transplantation. Read the full report: nej.md/4hDQNK4
#MedSky #Nephrology #Surgery
#MedSky #Nephrology #Surgery
November 10, 2025 at 6:31 PM
A follow-up report showed that the overall benefit of machine perfusion over cold storage in kidney graft survival remained present 10 years after transplantation. Read the full report: nej.md/4hDQNK4
#MedSky #Nephrology #Surgery
#MedSky #Nephrology #Surgery
Reposted by Michelle Rheault, MD
Summary from the #NephJC team of day 3
www.nephjc.com/news/2025/11...
Since we had only two trials simul-published today at #KidneyWk we took some creative license on what to include !
@nephroseeker.medsky.social with the beautiful graphics and tables apart from the lion’s share of writing!
www.nephjc.com/news/2025/11...
Since we had only two trials simul-published today at #KidneyWk we took some creative license on what to include !
@nephroseeker.medsky.social with the beautiful graphics and tables apart from the lion’s share of writing!
Kidney Week in Houston: Day 3 — NephJC
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies,
www.nephjc.com
November 9, 2025 at 4:28 AM
Summary from the #NephJC team of day 3
www.nephjc.com/news/2025/11...
Since we had only two trials simul-published today at #KidneyWk we took some creative license on what to include !
@nephroseeker.medsky.social with the beautiful graphics and tables apart from the lion’s share of writing!
www.nephjc.com/news/2025/11...
Since we had only two trials simul-published today at #KidneyWk we took some creative license on what to include !
@nephroseeker.medsky.social with the beautiful graphics and tables apart from the lion’s share of writing!
Reposted by Michelle Rheault, MD
Late breakers that included children:
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
November 8, 2025 at 10:29 PM
Late breakers that included children:
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
November 8, 2025 at 8:27 PM
Late breakers that included children:
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk